Volume 30, Issue 140 (May & June 2022)                   J Adv Med Biomed Res 2022, 30(140): 249-254 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Eskandarifar A, Mohammadi Baneh A, Alizadeh H. Evaluation of Hypothyroidism in Patients with Chronic Kidney Disease in Western Iran. J Adv Med Biomed Res 2022; 30 (140) :249-254
URL: http://journal.zums.ac.ir/article-1-6420-en.html
Evaluation of Hypothyroidism in Patients with Chronic Kidney Disease in Western Iran
Alireza Eskandarifar * 1, Anvar Mohammadi Baneh2 , Hamide Alizadeh3
1- Dept. of Pediatric, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran , are1345@yahoo.com
2- Dept. of Nephrology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
3- Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
Abstract:   (84813 Views)

Background and Objective: Chronic kidney disease (CKD)  determined by permanent kidney damage. Due to the similarity of clinical symptoms of hypothyroidism with CKD, hypothyroidism may be neglected and remain untreated. The goal of our study was to evaluate the rate of hypothyroidism in CKD patients who need hemodialysis.
Materials and Methods: This is a cross-sectional research. The sampling method was census and included all CKD patients in need of hemodialysis, who had undergone hemodialysis for at least three months. Serum levels of thyroid stimulating hormone (TSH), thyroxine (T4) and triiodothyronine (T3) hormones were measured in these patients, then the collected data were statistically analyzed.
Results: We studied 108 patients, 58 males (53.7%) and 50 females (46.3%). The mean age of the patients was 61.09 ± 13.45 years. The mean serum levels of hormones were as follows: TSH:1.64±1.78 µIL/ml,  T3:0.88 ± 0.2ng/dl, and  T4:7.7±1.6 µg/dl.
In this study, 7.4% of the patients had high TSH levels, 3.7% of the patients had decreased T4 levels and 10.2% of the patients had lower than normal T3 levels.
Conclusion: The rate of hypothyroidism in CKD patients who needed hemodialysis was higher than the normal population. It is recommended that serum TSH, and T4 levels in CKD patients be measured regularly to detect subclinical hypothyroid cases.

Keywords: Chronic kidney disease, Hypothyroidism, Hemodialysis, Western Iran
Full-Text [PDF 332 kb]   (40575 Downloads) |   |   Full-Text (HTML)  (1326 Views)  

✅ The rate of hypothyroidism in CKD patients who needed hemodialysis was higher than the normal population. It is recommended that serum TSH, and T4 levels in CKD patients be measured regularly to detect subclinical hypothyroid cases.


Type of Study: Original Article | Subject: Clinical medicine
Received: 2021/02/5 | Accepted: 2021/06/24 | Published: 2022/04/1
References
1. Shamsuddin M, Baig M S A, Hemalatha, Kumari S. Thyroid dysfunctions in patients with chronic renal failure. Int J Biol Med Res. 2014; 5(1): 3911-14
2. Khajehdehi P , Malekmakan L , Pakfetrat M , Roozbeh J , Sayadi M. Prevalence of chronic kidney disease and its contributing risk factors in Southern Iran: a cross-sectional adult population-based study. Iran J Kidney Dis. 2014 :8: 2:109-115
3. Levey A S, Coresh J, Bolton K, et al. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39 (2 suppl 1): S1-S266.
4. Mansourian, A.R. A review of literature on thyroid hormone disorders originated from extra thyroidal illness. J Biol Sci. 2014; 14 (1);20-37 [DOI:10.3923/jbs.2014.20.37]
5. Hizli Ş, Arsalan N, Abaci A, Buyukgebiz B. Subclinical hypothyroidism in obese Turkish adolescents: the relationship with anthropometry and fatty liver. Turk J Med Sci. 2010; 40 (2): 287-92
6. Bajaj S, Purwar N, Gupta A, Gupta P, Srivastava A. Prevalence of hypothyroidism in nondiabetic chronic kidney disease and effect of thyroxine replacement on estimated glomerular filtration rate. Indian J Nephrol. 2017; 27(2): 104-107 [DOI:10.4103/0971-4065.181464] [PMID] [PMCID]
7. Niemczyk S, Niemczyk L, Ciepielewska K R. Basic endocrinological disorder in chronic renal failure. Polish J Endocrinol. 2012; 63 (3): 250 -57
8. Chonchol M, Lippi G, Salvagno G, Zoppini G, Muggeo M, Targher G. Prevalence of subclinical hypothyroidism in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2008; 3: 1296-1300 [DOI:10.2215/CJN.00800208] [PMID] [PMCID]
9. Allawi A. Prevalence of hypothyroidism in chronic kidney disease among sample of Iraqi Patients. J Fac Med Baghdad. 2013; 55(2): 97-103
10. Yuasa R, Ohashi Y, Saito A, Tsuboi K, Shishido S, Sakai K. Prevalence of hypothyroidism in Japanese chronic kidney disease patients. Renal Failure. 2020; 42(1): 572-579 [DOI:10.1080/0886022X.2020.1777162] [PMID] [PMCID]
11. Chandra A. Prevalence of hypothyroidism in patients with chronic kidney disease: a cross-sectional study from North India. Kidney Res Clin Pract. 2016; 35(3):165-8. [DOI:10.1016/j.krcp.2016.06.003] [PMID] [PMCID]
12. Azami M, Parizad N, Sayehmiri K. Prevalence of hypothyroidism, hypoparathyroidism and the frequency of regular chelation therapy in patients with thalassemia major in Iran: A systematic review and meta-analysis study. Iran J Ped Hematol Oncol. 2016; 6 (4) :261-276
13. Pan B, Du X, Zhang H, Hua X, Wan X, Cao C. Relationships of chronic kidney disease and thyroid dysfunction in non-dialysis patients: A pilot study. Kidney Blood Press Res. 2019; 44:170-8 [DOI:10.1159/000499201] [PMID]
14. Aminorroaya A, Meamar R, Amini M, Feizi A, Tabatabae A, Imani EF. Incidence of thyroid dysfunction in an Iranian adult population: the predictor role of thyroid autoantibodies: results from a prospective population-based cohort study. Eur J Med Res. 2017; 22,21 [DOI:10.1186/s40001-017-0260-2] [PMID] [PMCID]
15. Demet Y, Siren S, Rahman Y, et al. Free triiodothyronine in hemodialysis patients link with malnutrition and inflammation. Iran J Kidney Dis. 2014 ; 8 (3); 212 - 17
16. Iglesias P, Diez JJ. Thyroid dysfunction and kidney disease. Eur J Endocrinol. 2009; 160(4): 503-15. [DOI:10.1530/EJE-08-0837] [PMID]
17. Cotoi L, Borcan F, Sporea I, et al. Thyroid pathology in end-stage renal disease patients on hemodialysis. Diagnostics. 2020; 10(4): 245 [DOI:10.3390/diagnostics10040245] [PMID] [PMCID]
18. Alsaran K, Sabry A, Alshahhat H, Babgy E, Alzahrani F. Free thyroxine, free triiodothyronine and thyroid-stimulating hormone before and after hemodialysis in Saudi patients with end-stage renal disease: Is there any difference?. Saudi J Kidney Dis Transpl. 2011; 22:917-21
19. Fan J, Yan P, Wang Y, Shen B, Ding F, Liu Y. Prevalence and clinical significance of low T3 syndrome in non-dialysis patients with chronic kidney disease. Med Sci Monit. 2016;22: 1171-79 [DOI:10.12659/MSM.895953] [PMID] [PMCID]
20. Emami N A, Darvishnia S, Khalili N, Norouzi Bazzaz A, Khazaei M, Shobeyri A. Thyroid function markers in patients receiving hemodialysis and peritoneal dialysis for chronic kidney disease. J Isfahan Med Sch. 2013; 31 (224): 59 -68
21. Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F. Low triiodothyronine: A new facet of inflammation in end-stage renal disease. J Am Soc Nephrol. 2005; 16: 2789-95 [DOI:10.1681/ASN.2005040356] [PMID]
22. Jusufovic S, Hodzic E. Functional thyroid disorders are more common in patients on chronic hemodIalysis compared with the general population. Mater Soc. 2011; 23(4): 206-209 [DOI:10.5455/msm.2011.23.206-209] [PMID] [PMCID]
23. Zeraati AA, Layegh P, Famili Y, Naghibi M Sharifipour F, Shariati SZ. Serum triiodothyronine level as an indicator of inflammation in patients undergoing dialysis. Iran J Kidney Dis. 2011; 5(1): 38-44
24. Walsh JP, Bremner AP, Bulsara MK, et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med. 2005;165 :2467- 2472 [DOI:10.1001/archinte.165.21.2467] [PMID]
25. Hergenc G, Onat A, Albayrak S. TSH Levels in Turkish adults: Prevalences and associations with serum lipids, coronary heart disease and metabolic syndrome. Turk J Med Sci. 2005; 35: 297-304
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb